pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,101 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT800Endpoints604BioPharma Dive231onclive165Fierce Biotech74BioSpace70raps29
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6
  • STAT+: A key European clinical trial registry lacks complete and timely results, an analysis finds
    A new analysis found that results for less than half of the clinical studies registered in a key European database were reported within the required time frame.
    STAT · 1mo ago↗ source
  • Covid vaccination cut risk of adverse heart events, large study finds
    Covid vaccination was also tied to a nearly 24% reduction in all-cause cardiac events in a large study, surprising researchers.
    STAT · 1mo ago↗ source
  • Medicare drug price rule may target under-the-skin Keytruda and Opdivo
    For 2029, a federal rule proposes closing a "loophole" that protects medicines transitioning from intravenous administration from price protection.
    BioPharma Dive · 1mo ago
← prev
page 21 of 45
next →
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
↗ source
  • Lilly scores early positive data for new JAK drug
    Acquired through its purchase of Ajax, the drug showed encouraging effects in patients with hard-to-treat myelofibrosis. To analysts, such results could lead to competition for Incyte’s Jakafi.
    BioPharma Dive · 1mo ago↗ source
  • J&J multiple myeloma drug gains edge in earlier stage disease
    The latest results studying Talvey in combination with Darzalex Faspro support J&J’s efforts to expand the immunotherapy's use.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Lilly’s Ajax acquisition may have been worth it
    A syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The Readout
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more
    Pfizer hasn't complied with a request to donate emergency penicillin to state health agencies as a backstop to prevent congenital syphilis
    STAT · 1mo ago↗ source
  • STAT+: Where ‘democracy met science,’ 50 years ago
    State Medicaid crackdowns strain home care, WHO leader on Ebola outbreak, and more health news
    STAT · 1mo ago↗ source
  • Celiac disease is entering a new era of therapeutic innovation
    For the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.
    BioPharma Dive · 1mo ago↗ source
  • Planning a successful pivot from lab to clinic
    For sterile injectables, key early decisions can have a significant impact on the products’ development.
    BioPharma Dive · 1mo ago↗ source
  • Opinion: In many South Asian American families, a child’s autism diagnosis is a secret
    “In South Asian households, a child's disability triggers a specific kind of family crisis,” writes child and adolescent psychiatrist Ritu Goel.
    STAT · 1mo ago↗ source
  • Opinion: I’m a pediatrician. I want to prescribe the right AI to my patients
    AI for children requires “randomized controlled trials measuring real developmental outcomes, not engagement metrics,” writes Dua Hassan.
    STAT · 1mo ago↗ source
  • STAT+: One California politician’s unexpected crusade against ultra-processed food
    Jesse Gabriel "has passed more food policy in three years than most legislators enact in their entire careers," says one supporter.
    STAT · 1mo ago↗ source
  • STAT+: Amid confusion over Pfizer’s emergency penicillin program, newborn is diagnosed with preventable syphilis
    Congenital syphilis should be preventable. An Arizona case shows how drug shortages and procedural hurdles are fueling a growing public health crisis.
    STAT · 1mo ago↗ source
  • As states follow Trump’s Medicaid fraud playbook, people with disabilities struggle to find care
    Medicaid cuts and fraud crackdown trickle down to states, threatening people with disabilities.
    STAT · 1mo ago↗ source
  • STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes
    The FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.
    STAT · 1mo ago↗ source
  • WHO director-general is profoundly concerned after visit to Ebola outbreak area
    The director-general of the World Health Organization is profoundly worried about the Ebola outbreak in the DRC, he told STAT in an interview.
    STAT · 1mo ago↗ source
  • Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73
    "There are some physicians that work to 100”: Dawn Zuidgeest-Craft on becoming a medical doctor in her 70s.
    STAT · 1mo ago↗ source
  • STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole
    Trump administration revisits policy to plug Medicare drug price negotiation loophole.
    STAT · 1mo ago↗ source
  • STAT+: Up and down the ladder: The latest comings and goings
    From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
    STAT · 1mo ago↗ source
  • STAT+: Prometheus raises $12 billion in capital for artificial engineers
    Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news
    STAT · 1mo ago↗ source
  • Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
    In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company is confident it can join the ranks of successful, commercial-stage brain drugmakers.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
    The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta
    STAT · 1mo ago↗ source
  • Chile offers new data on food warning label efficacy
    Kennedy's "publicly" "available" "calendar," drinking during pregnancy, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • Opinion: I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule
    “American science is too valuable to be turned into a political football,” writes David J. Skorton, president of the Association of American Medical Colleges.
    STAT · 1mo ago↗ source